Skip to main content

MoneyWorks4Me

Dr Reddys Laboratories informs about press release

19 Apr 2016 Evaluate

Dr Reddys Laboratories has informed about a Press Release dated April 19, 2016 titled ‘ZEMBRACE SymTouch (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the US’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..